Schonfeld Strategic Advisors’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,700
| Closed | -$135K | – | 2265 |
|
|
2023
Q4 | $135K | Hold |
5,700
| – | – | ﹤0.01% | 1498 |
|
|
2023
Q3 | $115K | Sell |
5,700
-24,382
| -81% | -$493K | ﹤0.01% | 1341 |
|
|
2023
Q2 | $782K | Sell |
30,082
-1,464
| -5% | -$38.1K | 0.01% | 1042 |
|
|
2023
Q1 | $656K | Buy |
31,546
+2,884
| +10% | +$60K | 0.01% | 1074 |
|
|
2022
Q4 | $585K | Buy |
28,662
+4,630
| +19% | +$94.5K | ﹤0.01% | 1432 |
|
|
2022
Q3 | $663K | Buy |
24,032
+9,362
| +64% | +$258K | 0.01% | 1526 |
|
|
2022
Q2 | $387K | Buy |
14,670
+1,426
| +11% | +$37.6K | ﹤0.01% | 1438 |
|
|
2022
Q1 | $1.06M | Sell |
13,244
-1,380
| -9% | -$110K | 0.01% | 905 |
|
|
2021
Q4 | $2.98M | Buy |
14,624
+1,083
| +8% | +$221K | 0.03% | 545 |
|
|
2021
Q3 | $4.38M | Buy |
13,541
+2,623
| +24% | +$848K | 0.05% | 433 |
|
|
2021
Q2 | $2.84M | Buy |
10,918
+325
| +3% | +$84.4K | 0.03% | 585 |
|
|
2021
Q1 | $4.09M | Buy |
10,593
+6,746
| +175% | +$2.6M | 0.05% | 455 |
|
|
2020
Q4 | $1.61M | Buy |
+3,847
| New | +$1.61M | 0.02% | 629 |
|